Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Vareptacog Alfa

  • Novo Nordisk Drops Phase III Hemophilia Drug
    Novo Nordisk has confirmed it will drop further development of the hemophilia therapy candidate vareptacog alfa, as a consequence of reports in August that some patients in a Phase ...
    10-1-2012

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll